Literature DB >> 22505855

Restless legs syndrome: what have we learned from prevalence studies and how will incidence studies further clinical knowledge?

Daniel L Picchietti1, Matthew A Picchietti.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22505855      PMCID： PMC3311407          DOI： 10.5664/jcsm.1758

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  18 in total

1.  The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics").

Authors:  Wayne A Hening; Richard P Allen; Mystinna Washburn; Suzanne R Lesage; Christopher J Earley
Journal:  Sleep Med       Date:  2009-01-29       Impact factor: 3.492

2.  Antidepressant medication use and restless legs syndrome in patients presenting with insomnia.

Authors:  Lee K Brown; David L Dedrick; John W Doggett; Peter S Guido
Journal:  Sleep Med       Date:  2005-09       Impact factor: 3.492

3.  Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

Authors:  A J Rothdach; C Trenkwalder; J Haberstock; U Keil; K Berger
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

4.  Elevated estradiol plasma levels in women with restless legs during pregnancy.

Authors:  Andrea Dzaja; Renate Wehrle; Marike Lancel; Thomas Pollmächer
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

5.  Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women.

Authors:  Helena Hachul; Lia R A Bittencourt; Monica L Andersen; Mauro A Haidar; Edmund C Baracat; Sergio Tufik
Journal:  Int J Gynaecol Obstet       Date:  2008-09-23       Impact factor: 3.561

6.  Increased frequency of restless legs syndrome in chronic obstructive pulmonary disease patients.

Authors:  Daniele Lo Coco; Alfredo Mattaliano; Albino Lo Coco; Biagio Randisi
Journal:  Sleep Med       Date:  2008-11-08       Impact factor: 3.492

7.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

8.  Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause.

Authors:  J Wesstrom; S Nilsson; I Sundstrom-Poromaa; J Ulfberg
Journal:  Climacteric       Date:  2008-10       Impact factor: 3.005

9.  Predisposing factors of restless legs syndrome in pregnancy.

Authors:  Tuğba Tunç; Yeşim Sücüllü Karadağ; Funda Doğulu; Levent E Inan
Journal:  Mov Disord       Date:  2007-04-15       Impact factor: 10.338

10.  Restless legs syndrome in patients with chronic obstructive pulmonary disease.

Authors:  Yuksel Kaplan; Handan Inonu; Ayse Yilmaz; Serpil Ocal
Journal:  Can J Neurol Sci       Date:  2008-07       Impact factor: 2.104
View more
  1 in total

Review 1.  Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Authors:  Michele A Faulkner
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.